Treatment of AML in biological subgroups

Hematology. 2005:10 Suppl 1:281-85. doi: 10.1080/10245330512331390212.
No abstract available

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Age Factors
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Prognosis
  • Risk Factors